Tag: #Global Trends

Commercialization agreement for Nufymco biosimilar Zydus Lifesciences Global FZE, a subsidiary of Zydus, has entered into an agreement with Bioeq... Read more

Reinstating strict pandemic-era protocols Major healthcare systems across states such as Georgia, Ohio, Indiana, and New Jersey have reactivated pandemic-era... Read more

Japanese regulatory authorities have granted marketing approval for 'NIPRO'—a biosimilar referencing Stelara (ustekinumab) developed by Samsung Bioepis—aiming to provide high-quality,... Read more

Pharmaceutical giant AstraZeneca has significantly expanded its partnership with Niowave, securing a decade-long supply of Actinium-225 (Ac-225) to bolster its... Read more

A Baltimore court has issued an unprecedented ruling against Johnson & Johnson (J&J), awarding $1.56 billion to a single plaintiff—the... Read more

Boehringer Ingelheim has unveiled a strategic partnership with Rectify Pharmaceuticals to develop small-molecule therapies that enhance the function of the... Read more

Medical technology firm Hologic has released new experimental data strengthening the role of artificial intelligence (AI) in breast cancer screening.... Read more

As of December 22, 2025, AstraZeneca has officially ceased all production and commercial sales of Andexxa in the United States.... Read more

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has officially granted marketing authorization for lenacapavir (branded as Yeytuo) for... Read more